(Q44043595)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

12

Hiromitsu Kumada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

4

Fumitaka Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

11

Kenji Ikeda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

9

Masahiro Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

3

Yoshiyuki Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

7

Norio Akuta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

2

Yasuji Arase

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

5

Hitomi Sezaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

10

Satoshi Saitoh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

8

Takashi Someya

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Akihito Tsubota

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 March 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology and Hepatology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

426-432

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03534.X

Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03534.X

The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03534.X

The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03534.X

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03534.X

Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03534.X

Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03534.X

Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03534.X

Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03534.X

Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03534.X

10.1111/J.1440-1746.2004.03534.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15740488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference